Generable
Generable: A precision medicine platform leveraging advanced probabilistic programming for optimal clinical decisions.
Generable: A precision medicine platform leveraging advanced probabilistic programming for optimal clinical decisions.
Generable, founded with a mission to revolutionize precision medicine, leverages advanced probabilistic programming, Bayesian inference, and multi-level regression and poststratification (MRP) to optimize clinical decisions. The platform aids in dose optimization, making go/no-go decisions from early clinical data, assessing the predictive power of biomarkers, and performing various other critical analyses. Generable primarily focuses on the healthcare and pharmaceutical markets, aiming to enhance the efficacy and efficiency of clinical trials and personalized treatment plans.
Notable figures affiliated with Generable include experts in probabilistic programming and Bayesian inference, contributing to the platform's robust analytical capabilities. The company has attracted significant interest from investors focused on healthcare innovation. Key achievements include successful collaborations with leading pharmaceutical companies and impactful publications in scientific journals. Generable's platform has significantly improved decision-making processes in clinical trials, contributing to more effective and personalized patient care.
Companies similar to Generable include Probably Genetic, PhaseV, InsightRX and Genterpret.
Generable was founded in 2016.
Generable's headquarters is located in New York City, NY, US.
Generable's most recent funding round was for $120k (USD) in January 2017.
As of Jan 16, 2017, Generable has disclosed funding of $120k (USD). Undisclosed round amounts are excluded.
Generable has 5 employees as of Feb 4, 2024.
Genterpret
